In which client would patient-controlled analgesia (pca) be contraindicated?
Disclosure of Relevant Financial Relationships: As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), the University of California, Davis, Health must ensure balance, independence and objectivity in all its CME activities to promote improvements in health care and not proprietary interests of a commercial interest. Authors, reviewers and others in a position to control the content of this activity are required to disclose relevant financial relationships with commercial interests related to the subject matter of this educational activity. The Accreditation Council for Continuing Medical Education (ACCME) defines a commercial interest as “any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients” and relevant financial relationships as “financial relationships in any amount occurring within the past 12 months that create a conflict of interest. Show Patrick Romano, MD; Deborah Bakerjian, MD; Ulfat Shaikh, MD; Rachelle Firestone, PharmD; Sarina Fazio, PhD; Patricia Poole, PharmD (author(s) and reviewers) for this Spotlight Case and Commentary have disclosed no relevant financial relationships with commercial interests related to this CME activity. Case Objectives
The CaseA 69-year-old man with a history of cervical stenosis, coronary artery disease, chronic kidney disease, and hypertension developed worsening neck pain in the previous year, which prevented him from working, performing household tasks, and socializing with friends. Due to severe osteoarthritis and pain in his knees, he used a motorized scooter. The patient was admitted for elective surgery for decompression and to extend a prior C3-C6 fusion down to T3. Surgery was performed which concluded at approximately 13:00. The patient recovered in the post-anesthesia care unit (PACU), where he was placed on hydromorphone patient-controlled analgesia (PCA) for pain control and also received his usual home doses of gabapentin and acetaminophen. The patient was transferred from the PACU to the surgical floor at 20:00 where supplemental oxygen was placed for a peripheral oxygen saturation measurement (SpO2) of 88%. The patient was awake and participating in care until 02:45. At 04:05, the patient was found unresponsive and a Code Blue was called. He was initially responsive to resuscitation efforts, and was transferred to the intensive care unit, where he arrested twice more. Tests the next day confirmed brain death and ventilatory support was withdrawn. The CommentaryBy Sarina Fazio, PhD, RN and Rachelle Firestone, PharmD, BCCCP Patient-Controlled Analgesia Patient-controlled analgesia (PCA) is widely used for postoperative intravenous opioid administration to promote pain management by enabling patient control of medication administration frequency. PCA involves opioid administration via an infusion pump that delivers a preprogrammed dose of opioid when the patient pushes a demand button with or without a constant-rate background infusion. A lockout interval on the demand dose, usually 6-15 minutes, helps prevent overdose, as well as “dose stacking”, and can be adjusted depending on the opioid chosen and patient-specific factors such as opioid tolerance and risk for respiratory depression. The PCA method avoids the peaks and troughs of analgesia typically seen with as needed (PRN) opioid administration and allows for more individualized dosing to achieve a predictable pain relief response. Common side effects of opioid administration delivered through PCA include nausea and vomiting, pruritis, sedation, confusion, and respiratory depression. Opioid-Induced Respiratory Depression Opioid-induced respiratory depression involves a combination of decreased respiratory drive, decreased level of consciousness, and upper airway obstruction due to a decrease in supraglottic airway tone. In a 2018 review, the cumulative incidence of opioid-induced respiratory depression in postoperative patients was reported to be between 0.1% and 23.7%, due to variations in respiratory depression definitions. The criteria for defining opioid-induced respiratory depression can include respiratory rate less than 8–10 bpm, SpO2 less than 90%, airway obstruction, over-sedation, naloxone administration, respiratory arrest and/or cardiopulmonary resuscitation. Additionally, the true incidence of opioid-inducted respiratory depression may be challenging to determine because respiratory depression can resolve without leading to a sentinel event. For many patients, while PCA is considered safer than continuous intravenous opioid administration, and has fewer logistical considerations than epidural analgesia, it can result in critical respiratory depression events with significant consequences. PCA is associated with some risk of opioid-induced respiratory depression leading to significant morbidity and mortality. From 2002 to 2011, the incidence of postoperative opioid overdose doubled from 0.6 to 1.1 per 1000 operative cases. In a review of claims made between 1990 and 2009 from the Anesthesia Closed Claims Project Database, 26% involved likely opioid-induced respiratory depression, of which 77% resulted in severe brain damage or death. Most of these opioid-related injuries occurred within 24 hours of surgery and were deemed to have been preventable with better monitoring and clinician response. Another review of nationally reported opioid-related sentinel events concluded that over 75% of all events were attributed to either medication errors involving wrong dose or improper monitoring. The overwhelming majority of PCA errors, which can occur at any phase of the medication-use process, are associated with human factors. These errors are associated with prescribing (incomplete or contradictory orders, failure to adjust for organ dysfunction or comorbid conditions), dispensing (compounding errors, look alike/sound alike errors), and administration (pump mis-programming for drug, dose, or concentration; lack of continuous monitoring). As a result of the preventable morbidity and mortality associated with opioid-induced respiratory depression in acute care hospitals, The Joint Commission released an alert in 2012 recommending that institutions implement policies and procedures to minimize the risk of respiratory depression associated with opioid administration. Best Practices in Opioid PCA Use Due to the significant risks of mortality and morbidity associated with opioid PCA administration, many best practices have been recommended. These best practices include, but are not limited to, comprehensive identification and assessment of high-risk patients, standardized guidelines for PCA prescribing and administration, and ongoing patient monitoring of oxygenation and ventilation, as summarized below. Identification and Assessment of High-Risk Patients Risk factors for opioid-induced respiratory depression associated with PCA among postoperative patients include patient-, comorbidity-, and surgical-related risk factors.,, Table 1 summarizes the risk factors identified in each category. Patient-related factors include advanced age, female sex, and opioid dependence., Specifically, preoperative use of gabapentin (greater than 300 mg) and sustained released oxycodone (greater than 10 mg) were associated with opioid-induced respiratory depression among patients undergoing orthopedic surgery. Comorbidities such as obstructive sleep apnea (OSA), renal disease, pulmonary disease, cardiac disease, neurological disease, and obesity also are associated with increased risk of opioid-induced respiratory depression.,, Analysis of the Anesthesia Closed Claims Project revealed that 45% of patients with respiratory depression had confirmed or suspected OSA and 66% were morbidly obese. OSA is also common among patients with fatal respiratory depression. A retrospective study of general surgery patients who died as a result of opioid-induced respiratory depression found that 50% had OSA. Table 1. Risk Factors for Opioid-Induced Respiratory Depression Patient CharacteristicsComorbiditiesSurgical & Perioperative
Table adapted from Gupta 2018 and modified with risk factors presented in the following references: Jazyrna 2011, Arozullah 2003. Identification of patients at higher risk for opioid-induced respiratory depression prior to surgery has been recommended, especially to assess for OSA. The STOP-BANG questionnaire is an 8-item tool to screen for OSA (www.stopbang.ca/osa/screening.php). The tool assesses a patient’s risk for OSA based on a score calculated from questions related to snoring, daytime fatigue, waking up at night, hypertension, body mass index (BMI), age, neck circumference, and gender. Calculation of BMI and serum bicarbonate level is also recommended to screen for obesity hypoventilation syndrome, which additionally puts patients at risk for opioid-induced respiratory depression. In the case described, the patient had multiple risk factors for an opioid-induced respiratory event: age > 55, elevated serum creatinine level, and home use of gabapentin. The risk of a postoperative respiratory event might have been reduced by preoperative evaluation for OSA using the STOP-BANG questionnaire and development of a risk-based postoperative pain management plan before surgery. PCA Prescribing and Administration The safety of opioid use in high-risk patients can be improved through development of standardized pain order sets that highlight proper patient selection (opioid-naïve versus opioid-tolerant), emphasize oral opioids, and utilize multi-modal pain management strategies. When PCA is used as the modality of choice, additional safeguards are necessary to prevent patient harm due to the complexity of the process (Table 2). For all types of PCA, the following variables must be prescribed by a provider and programmed by staff: drug concentration, initial loading dose, demand dose, lockout interval, and background infusion rate. Each of these steps contributes opportunities for error. Additional risks include activation of PCA by others (usually well-meaning family, or “PCA by proxy”) and equipment failure. Table 2. Best Practices for Opioid PCA Use PrescribingDispensingAdministration
Table adapted from ISMP 2003 and the San Diego Patient Safety Council Tool Kit 2009. Implementation of standardized PCA order sets has been shown to mitigate risks associated with PCA and decrease the incidence of respiratory depression events. Order set standardization should leverage clinical decision support to guide opioid selection, doses, and lockout periods, and should include embedded rescue naloxone orders. Given its potency and availability in high concentration, hydromorphone is ideally suited for opioid-tolerant patients but should be avoided as a first-line opioid choice for opioid naïve patients., In the case described, the patient was prescribed hydromorphone PCA without a continuous basal rate. Several important policy changes were made at an institution level in response to this fatal event, including development of standardized pain order sets and guidelines for inpatient opioid administration. An educational emphasis was also placed on opioid selection for high-risk patients, with prompts to guide the prescriber based on patient-specific factors such as organ dysfunction and comorbid conditions such as OSA and renal insufficiency. Postoperative Monitoring of Patients Receiving PCA Patient monitoring involves regular observation, assessment and documentation of patient responses to opioid administration. In postoperative patients receiving intravenous opioid PCA, vital signs, pain level, sedation status, and respiratory status, including oxygenation and ventilation, should be monitored and assessed (Table 3). A growing body of evidence and expert consensus support the use of capnography (ETCO2) as well as pulse oximetry (SpO2) to monitor patient oxygenation and ventilation. Capnography measures the partial pressure of carbon dioxide in exhaled gases and can detect ventilatory abnormalities such as respiratory depression before oxygen desaturation occurs, especially when supplemental oxygen is administered., Table 3. Monitoring for Patients Receiving Opioid PCA Monitoring ComponentAssessment TypesVital SignsHeart Rate Blood Pressure PainNumeric Rating Scale Faces Pain Scale Iowa Pain Thermometer OxygenationPulse Oximetry (SpO2)VentilationRespiratory Rate (RR) Capnography (ETCO2) Sedation and ConsciousnessPasero Opioid Scale (POSS) Aldrete Score Glasgow Coma Scale Richmond Agitation-Sedation Scale (RASS) Table adapted from Jungquist 2017. While continuous monitoring of oxygen saturation and capnography can help identify respiratory depression, recommendations for the timing and duration of monitoring can differ among organizations. Societies agree that the timing of assessments should coincide with peak drug effects and that monitoring should occur more frequently for high risk patients.
Patient-specific monitoring plans should reflect the type and route of opioid administration, post-procedural level of care, patient response to treatment and risk of adverse events. However, evidence increasingly supports continuous monitoring of patients receiving intravenous opioids through PCA. In a recent systematic review, the authors found that continuous SpO2 monitoring on the surgical ward is associated with significant improvement in the detection of oxygen desaturation compared with intermittent nursing spot-checks. While the first 24-hours after surgery have the highest risk of opioid-induced respiratory depression, deaths most frequently occur overnight between 00:00-06:00 am when nurse staffing and monitoring frequency may decrease in an effort to promote sleep., In 42% of cases reviewed in the Anesthesia Claims database, the interval between the last nursing assessment and detection of respiratory depression was less than two hours, further supporting the value of continuous monitoring. While recommendations related to monitoring for patients receiving PCA may vary, increasing the type and frequency of patient monitoring should be considered and discussed among members of the interprofessional team (MD, RN, PharmD) under any of the following circumstances:
In the case described herein, the patient was monitored at the prescribed monitoring intervals. However, the need for supplemental O2 was a potential indicator that continuous SpO2 and end tidal CO2 monitoring would have been prudent. In addition, a standardized PCA handoff tool from the PACU to the surgical unit might have alerted the nursing staff to the patient’s risk factors for opioid-induced respiratory depression. Take-Home Points
Sarina Fazio, PhD, RN Rachelle L. Firestone, PharmD, BCCCP References
Take the Quiz This project was funded under contract number 75Q80119C00004 from the Agency for Healthcare Research and Quality (AHRQ), U.S. Department of Health and Human Services. The authors are solely responsible for this report’s contents, findings, and conclusions, which do not necessarily represent the views of AHRQ. Readers should not interpret any statement in this report as an official position of AHRQ or of the U.S. Department of Health and Human Services. None of the authors has any affiliation or financial involvement that conflicts with the material presented in this report. View AHRQ Disclaimers PPT Save Save to your library Share Copy URL Sections Related Resources WebM&M Cases Open wider: Failure to use an interpreter results in fractured teeth and hypoxia during a simple elective operation. December 14, 2022 WebM&M Cases Don’t Bite Your Tongue. December 14, 2022 Potentially inappropriate medication administration is associated with adverse postoperative outcomes in older surgical patients: a retrospective cohort study. September 14, 2022 WebM&M Cases Perioperative Anaphylaxis After Insertion of a Latex Drain in a Patient with Known Latex Allergy August 31, 2022 Preventing patient positioning injuries in the nonoperating room setting. August 24, 2022 APSF endorsed statement on revising recommendations for patient monitoring during anesthesia. May 4, 2022 WebM&M Cases Intraosseous Line Extravasation in a Pediatric Trauma Patient April 27, 2022 WebM&M Cases Saline Flush Leads to Acute Paralysis of an Awake Patient: Risks of Improper Medication Labeling in an Operating Room April 27, 2022 Annual Perspective Annual Perspective: Topics in Medication Safety March 31, 2022 Increased adherence to perioperative safety guidelines associated with improved patient safety outcomes: a stepped-wedge, cluster-randomised multicentre trial. February 9, 2022 Filling the gaps on the Institute for Safe Medication Practices (ISMP) Do Not Crush List for Immediate-release Products December 22, 2021 WebM&M Cases To Dilute or Not Dilute: Drug Errors and Consequences in the Operating Room October 27, 2021 Using performance improvement to enhance time-out compliance and prevent wrong-site surgery. August 11, 2021 Meitheal Pharmaceuticals, Inc. issues voluntary nationwide recall of Cisatracurium Besylate Injection, USP 10mg per 5mL due to mislabeling. February 10, 2021 WebM&M Cases Multiple High-Risk Events Involving Workflow for Wasting of Medications Used by Anesthesia July 29, 2020 WebM&M Cases When the Indications for Drug Administration Blur June 24, 2020 WebM&M Cases Is that solution for IV or irrigation?: Fluid administration errors in the operating room. March 25, 2020 WebM&M Cases Discharged with IV antibiotics: When issues arise, who manages the complications? February 26, 2020 WebM&M Cases A Mistaken Dose of Naloxone December 18, 2019 WebM&M Cases Cardiac Arrest in a Woman with UTI: A Case of QT Prolongation November 27, 2019 WebM&M Cases Adverse Event During Intrahospital Transport February 1, 2019 Infection prevention in the operating room anesthesia work area. January 30, 2019 WebM&M Cases One Bronchoscopy, Two Errors January 1, 2019 WebM&M Cases Inadequate Preanesthetic Evaluation, Airway Trouble November 1, 2018 Safe handling of concentrated electrolyte products from outsourcing facilities during critical drug shortages. June 13, 2018 Risk factors for i.v. compounding errors when using an automated workflow management system. July 27, 2016 Impact of a drug shortage on medication errors and clinical outcomes in the pediatric intensive care unit. February 3, 2016 Recommendations and low-technology safety solutions following neuromuscular blocking agent incidents. February 3, 2016 Medication safety in the operating room: a survey of preparation methods and drug concentration consistencies in children's hospitals in the United States. |